UK orders new monitoring and revision regime for all MoM hips
This article was originally published in SRA
The UK Medicines and Healthcare products Regulatory Agency has issued a device alert requiring that all patients with metal-on-metal (MoM) hip replacements undergo a tighter follow-up regime1.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.